Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CRTS
Singapore, Singaporecellresearchtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CellResearch Therapeutics (CRT) is a clinical-stage biotechnology company and a spin-out of CellResearch Corporation, a global leader in umbilical cord lining stem cell technology. The company leverages its proprietary platform to develop regenerative therapies using mesenchymal and epithelial stem cells harvested from the umbilical cord lining. Its lead program is focused on the treatment of diabetic foot ulcers, which has advanced into Phase 2 clinical trials. Beyond wound care, CRT is exploring applications in dermatology, including androgenetic alopecia, and other chronic conditions such as COPD and erectile dysfunction. The company's technology is supported by a robust patent portfolio covering the isolation and therapeutic use of these unique stem cell populations.
- Therapeutic areas
- ImmunologyEndocrinologyDermatologyPulmonologyMen's Health
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
02
Partnerships
MundipharmaUniversity of Colorado
Beyond the preview
Go deeper on CRTS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CRTS.